Prohibits a pharmacist from substituting any anti-epileptic drug for the prescribed anti-epileptic drug without notification of and the informed consent of the prescriber and patient or such patient's parent, guardian or spouse.
Requires certain NJ FamilyCare providers to provide information to, and obtain consent form from, parent or guardian of child that provider is prescribing antipsychotic drug.
Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.
Permits licensed pharmacists and nurse practitioners to prescribe and order COVID-19 immunizations; permits physicians to issue non-patient specific orders to pharmacists for COVID-19 immunizations for patients two years of age and older; permits pharmacists to issue patient specific orders for COVID-19 immunizations for patients two years of age and older.
Permits licensed pharmacists and nurse practitioners to prescribe and order COVID-19 immunizations; permits physicians to issue non-patient specific orders to pharmacists for COVID-19 immunizations for patients two years of age and older; permits pharmacists to issue patient specific orders for COVID-19 immunizations for patients two years of age and older.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals".